Investor Alert

Indaptus Therapeutics Inc.



After Hours

 --Quotes are delayed by 20 min

Jun 29, 2022, 7:47 p.m.





+0.08 +3.52%


Volume 117

Quotes are delayed by 20 min


Today's close

$ 2.34

$ 2.27


-0.07 -2.99%

Day low

Day high




52 week low

52 week high




Annual Financials for Indaptus Therapeutics Inc.

Operating Activities

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Net Income before Extraordinaries (28.91M)(43.54M)(47.6M)(3.58M)(7.71M)
Depreciation, Depletion & Amortization 829,000859,000854,0008521,403
Depreciation and Depletion 829,000859,000854,0008521,403
Amortization of Intangible Assets -----
Deferred Taxes & Investment Tax Credit --281,000--
Deferred Taxes --281,000--
Investment Tax Credit -----
Other Funds 858,0004.25M17.19M139,9601.51M
Funds from Operations (27.22M)(38.43M)(29.27M)(3.44M)(6.2M)
Extraordinaries -----
Changes in Working Capital 5.09M(642,000)227,000118,711(5.09M)
Receivables 1.26M(1.86M)(747,000)--
Accounts Payable 3.83M1.19M679,000113,900(4.24M)
Other Assets/Liabilities -28,000295,0004,811(854,154)
Net Operating Cash Flow (22.13M)(39.08M)(29.05M)(3.32M)(11.29M)

Investing Activities

20172018201920202021 5-year trend
Capital Expenditures (5M)(9.6M)(921,000)-(3,854)
Capital Expenditures (Fixed Assets) (5M)(4.67M)(921,000)-(3,854)
Capital Expenditures (Other Assets) -(4.93M)---
Net Assets from Acquisitions -----
Sale of Fixed Assets & Businesses 7,000---451,600
Purchase/Sale of Investments 247,000298,000576,000--
Purchase of Investments -----
Sale/Maturity of Investments 247,000298,000576,000--
Other Uses --(2.87M)--
Other Sources -----
Net Investing Cash Flow (4.75M)(9.3M)(3.21M)-447,746

Financing Activities

20172018201920202021 5-year trend
Cash Dividends Paid - Total -----
Common Dividends -----
Preferred Dividends -----
Change in Capital Stock 63.71M35.06M2.37M-30.36M
Repurchase of Common & Preferred Stk. -----
Sale of Common & Preferred Stock 63.71M35.06M2.37M-30.36M
Proceeds from Stock Options 63.66M35.03M2.09M-29.97M
Other Proceeds from Sale of Stock 45,00030,000282,000-390,331
Issuance/Reduction of Debt, Net -----
Change in Current Debt -----
Change in Long-Term Debt -----
Issuance of Long-Term Debt -----
Reduction in Long-Term Debt -----
Other Funds ---1.16M17.97M
Other Uses ----(3.37M)
Other Sources ---1.16M21.35M
Net Financing Cash Flow 63.71M35.06M2.37M1.16M48.34M
Exchange Rate Effect 127,000(829,000)(67,000)--
Miscellaneous Funds -----
Net Change in Cash 36.96M(14.15M)(29.95M)(2.16M)37.49M
Free Cash Flow (27.13M)(43.74M)(29.97M)-(11.29M)
Link to MarketWatch's Slice.